Rational Drug Design of G-Quartet DNA as Anti-Cancer Agents

E-ISSN： 1873-4286|11|22|2841-2854

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.22, 2005-08, pp. : 2841-2854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing G-quartet oligonucleotides as novel anti-HIV agents: focus on anti-HIV drug design

By Jing N.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1777-1785

Informa Healthcare

Access to resources Recommend Favorite

G-quadruplex DNA: a potential target for anti-cancer drug design

By Han H. Hurley L.H.

Trends in Pharmacological Sciences, Vol. 21, Iss. 4, 2000-04 ,pp. : 136-142

Elsevier

Access to resources Recommend Favorite

The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?

By McCluskey A. Ackland1 S.P. Gardiner E. Walkom C.C. Sakoff1 J.A.

Anti-Cancer Drug Design, Vol. 16, Iss. 6, 2001-12 ,pp. : 291-303

Cognizant Communication Corporation

Access to resources Recommend Favorite

Structure-Based Drug Design, Molecular Dynamics and ADME/Tox to Investigate Protein Kinase Anti-Cancer Agents

Current Bioactive Compounds, Vol. 13, Iss. 3, 2017-07 ,pp. : 213-222

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: DNA Anti-Cancer Drug Design (Executive Editor: Naijie Jing)]

Current Pharmaceutical Design, Vol. 11, Iss. 22, 2005-08 ,pp. : 2809-2809

Bentham Science Publishers

Access to resources Recommend Favorite